EUVIMEDEUVIMED entdecken
Crossref

Fibroblast Growth Factor Receptor 1-Specific Dehydrogelation to Release Its Inhibitor for Enhanced Lung Tumor Therapy

Runqun Tang, Ziyi Zhang, Xiaoyang Liu iD, Liangxi Zhu, Yuting Xu, Renjie Chai iD, Wenjun Zhan iD, Shurong Shen, Gaolin Liang iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c11548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Runqun Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 211189, Chin…. Hauptthemen laut MEDLINE: Lung Neoplasms, Receptor, Fibroblast Growth Factor, Type 1, Mice, Nude, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsReceptor, Fibroblast Growth Factor, Type 1Mice, NudeAntineoplastic AgentsHumansAnimalsMiceIndolesHydrogelsCell MovementA549 CellsCell ProliferationCell SurvivalMice, Inbred BALB CProtein Kinase InhibitorsDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

FGFR1hydrogelkinase inhibitorsustained releasetumor therapy

Substanzen

Receptor, Fibroblast Growth Factor, Type 1Antineoplastic AgentsFGFR1 protein, humanIndolesHydrogelsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 211189, China.
  • Breast Surgery, Wenzhou Central Hospital, Wenzhou 325000, China.
  • State Key Laboratory of Digital Medical Engineering, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, Advanced Institute for Life and Health, Southeast University, Nanjing 210096, China.

ORCID-Profile: Xiaoyang Liu, Renjie Chai, Wenjun Zhan, Gaolin Liang

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Tang, R., Zhang, Z., Liu, X., Zhu, L., Xu, Y., Chai, R., Zhan, W., Shen, S., & Liang, G. (2024). Fibroblast Growth Factor Receptor 1-Specific Dehydrogelation to Release Its Inhibitor for Enhanced Lung Tumor Therapy. ACS Nano. https://doi.org/10.1021/acsnano.4c11548

Vancouver

Tang R, Zhang Z, Liu X, Zhu L, Xu Y, Chai R, et al. Fibroblast Growth Factor Receptor 1-Specific Dehydrogelation to Release Its Inhibitor for Enhanced Lung Tumor Therapy. ACS Nano. 2024. doi:10.1021/acsnano.4c11548

BibTeX
@article{Tang2024,
  author = {Tang, Runqun and Zhang, Ziyi and Liu, Xiaoyang and Zhu, Liangxi and Xu, Yuting and Chai, Renjie and Zhan, Wenjun and Shen, Shurong and Liang, Gaolin},
  title = {Fibroblast Growth Factor Receptor 1-Specific Dehydrogelation to Release Its Inhibitor for Enhanced Lung Tumor Therapy},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c11548}
}
Kostenlos starten →